LekoskopLekoskop
HR · ES · FR · CS · IT · NL · CH · UK · PL

Europska unija — odluke Europske komisije — kolovoz 2024.

Ukinuta odobrenja, povlačenje serija lijekova, pisma zdravstvenim radnicima i novi lijekovi EU — svakodnevno, automatski. Zadnje ažuriranje: 27. 9. 2026. 13:39

Sve Ukinuta odobrenja20 Povlačenje serija1 Novi lijekovi (EU)9 Sigurnost (DHPC)1 Europska unija37
poništi

Izvori: promjene pratimo na temelju informacija Agencije za lijekove i medicinske proizvode (HALMED) — rješenja o ukidanju odobrenja, obavijesti o povlačenju serija i pisma zdravstvenim radnicima. Odluke o centralizirano odobrenim lijekovima dolaze iz registra Unije Europske komisije (oznaka EU). Nestašice i liste lijekova HZZO-a ovdje (još) nisu uključene.

30. 8. 2024.petak, 30. kolovoza 2024.

otvori dan ◀ ▶ 1 događaj · 1 važnih
Ukinuto u EU EU Ocaliva
br. EU/1/16/1139 · odobreno 12. 12. 2016. · Ocaliva is indicated for the treatment of primary biliary cholangitis (PBC) in combination with ursodeoxycholi… · ADVANZ PHARMA Limited · obeticholic acid · ATC A05AA04
Što to znači, detalji

Učitavanje…

26. 8. 2024.ponedjeljak, 26. kolovoza 2024.

otvori dan ◀ ▶ 1 događaj
Novo odobrenje EU EU Havrix and associated names
GlaxoSmithKline Biologicals S.A. · inactivated hepatitis A virus
Što to znači, detalji

Učitavanje…

22. 8. 2024.četvrtak, 22. kolovoza 2024.

otvori dan ◀ ▶ 11 događaja
Novo odobrenje EU EU mRESVIA
br. EU/1/24/1849 · mRESVIA is indicated for active immunisation for the prevention of lower respiratory tract disease (LRTD) caus… · MODERNA BIOTECH SPAIN, S.L. · Single-stranded 5' capped mRNA encoding the respiratory syncytial virus glycoprotein F stabilized in the prefusion conformation · ATC J07BX05
Što to znači, detalji

Učitavanje…

Novo odobrenje EU EU Winrevair
br. EU/1/24/1850 · Winrevair, in combination with other pulmonary arterial hypertension (PAH) therapies, is indicated for the tre… · Merck Sharp & Dohme B.V. · sotatercept · ATC C02KX06
Što to znači, detalji

Učitavanje…

Novo odobrenje EU EU Tauvid
br. EU/1/24/1799 · This medicinal product is for diagnostic use only. Flortaucipir (18F) is a radiopharmaceutical indicated for … · Eli Lilly Nederland B.V. · Flortaucipir (18F) · ATC V09AX07
Što to znači, detalji

Učitavanje…

Novo odobrenje EU EU Steqeyma
br. EU/1/24/1844 · Adult Crohn’s Disease Steqeyma is indicated for the treatment of adult patients with moderately to severely a… · Celltrion Healthcare Hungary Kft. · ustekinumab · ATC L04AC05
Što to znači, detalji

Učitavanje…

Novo odobrenje EU EU Piasky
br. EU/1/24/1848 · Piasky as monotherapy is indicated for the treatment of adult and paediatric patients 12 years of age or older… · Roche Registration GmbH · crovalimab · ATC L04AJ07
Što to znači, detalji

Učitavanje…

Novo odobrenje EU EU Ordspono
br. EU/1/24/1843 · • Ordspono as monotherapy is indicated for the treatment of adult patients with relapsed or refractory follicu… · Regeneron Ireland Designated Activity Company (DAC) · odronextamab · ATC L01FX34
Što to znači, detalji

Učitavanje…

Novo odobrenje EU EU Nilotinib Accord
br. EU/1/24/1845 · Nilotinib Accord is indicated for the treatment of: - adult and paediatric patients with newly diagnosed Phil… · Accord Healthcare S.L.U. · nilotinib · ATC L01EA03
Što to znači, detalji

Učitavanje…

Novo odobrenje EU EU Enzalutamide Viatris
br. EU/1/24/1842 · Enzalutamide Viatris is indicated: • as monotherapy or in combination with androgen deprivation therapy for t… · Viatris Limited · enzalutamide · ATC L02BB04
Što to znači, detalji

Učitavanje…

Novo odobrenje EU EU EURneffy
br. EU/1/24/1846 · EURneffy is indicated in the emergency treatment of allergic reactions (anaphylaxis) due to insect stings or b… · ALK-Abelló A/S · Epinephrine · ATC C01CA24
Što to znači, detalji

Učitavanje…

Novo odobrenje EU EU Balversa
br. EU/1/24/1841 · Balversa as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic uroth… · Janssen-Cilag International NV · erdafitinib · ATC L01EN01
Što to znači, detalji

Učitavanje…

Novo odobrenje EU EU AKANTIOR
br. EU/1/24/1840 · AKANTIOR is indicated for the treatment of Acanthamoeba keratitis in adults and children from 12 years of age. · SIFI S.p.A. · polihexanide · ATC S01AX24
Što to znači, detalji

Učitavanje…

2. 8. 2024.petak, 2. kolovoza 2024.

otvori dan ◀ ▶ 1 događaj · 1 važnih
Povučeno u EU EU NYXTHRACIS
br. EU/1/20/1485 · odobreno 18. 11. 2020. · Obiltoxaximab SFL is indicated in combination with appropriate antibacterial drugs in all age groups for treat… · SFL Pharmaceuticals Deutschland GmbH · obiltoxaximab · ATC J06BC04
Što to znači, detalji

Učitavanje…

1. 8. 2024.četvrtak, 1. kolovoza 2024.

otvori dan ◀ ▶ 2 događaja
Novo odobrenje EU EU GalliaPharm
br. EU/1/24/1836 · This radionuclide generator is not intended for direct use in patients. The sterile eluate (gallium (68Ga)… · Eckert & Ziegler Radiopharma GmbH · germanium (<sup>68</sup>Ge) chloride / gallium (<sup>68</sup>Ga) chloride · ATC V09X
Što to znači, detalji

Učitavanje…

Novo odobrenje EU EU ADZYNMA
br. EU/1/24/1837 · ADZYNMA is an enzyme replacement therapy (ERT) indicated for the treatment of ADAMTS13 deficiency in children … · Takeda Manufacturing Austria AG · rADAMTS13 · ATC B01AD13
Što to znači, detalji

Učitavanje…

Ukupno 16 događaja u ovoj kategoriji.